Infinium Pharmachem IPO will open for subscription from 31 March 2023. the company aims for an issue size of ₹25.26 Cr through this IPO.
About Company
Incorporated in 2003, Infinium Pharmachem aims to manufacture and supply Iodine, Iodine Derivatives, and Active Pharmaceutical Ingredients (APIs). The company undertakes contract research and manufacturing services to provide customized and fully confidential solutions to its clients. Today, its manufacturing capabilities and technical expertise has allowed it to efficiently cater to numerous industries such as pharmaceutical & biotech, specialty & Performance chemicals, agrochemicals, human health, animal health, cosmetics, sanitation, electrical, electronics, and much more. Its manufacturing plant in Gujarat, provides the widest range of Iodine derivatives in the market, with more than 250+ intermediates and 15+ APIs.
Infinium Pharmachem IPO allotment status will be available on Bigshare Services’ website. Click on Bigshare Services weblinkto get allotment status.
Final thoughts
Infinium Pharmachem IPO is going to hit Dalal street soon. applying for an IPO is purely a personal choice. study well about the company and do subscribe if you are feeling good about the company. I hope this post will give you enough details to make a fundamental study of the company. learn well and make wise decisions.